Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan

Saved in:
Bibliographic Details
Published in:Breast Cancer : Targets and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868552785582096385
collection WordPress RSS
FRELIP Feed Integration
container_title Breast Cancer : Targets and Therapy
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:61071
institution FRELIP
journal_source_facet Breast Cancer : Targets and Therapy
last_indexed 2026-06-20T21:26:07.255Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan
title_alt Asociación de doxorrubicina liposomal pegilada con mejor supervivencia global en comparación con epirrubicina en cáncer de mama en estadio temprano: un estudio poblacional de Taiwán
Association de la doxorubicine liposomale pégylée avec une amélioration de la survie globale par rapport à l'épirubicine dans le cancer du sein à un stade précoce : une étude basée sur la population de Taïwan
Associação de doxorrubicina lipossomal peguilada com melhora na sobrevida global em comparação com epirrubicina no câncer de mama inicial: Um estudo populacional de Taiwan
title_auth Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan
title_es_txt Asociación de doxorrubicina liposomal pegilada con mejor supervivencia global en comparación con epirrubicina en cáncer de mama en estadio temprano: un estudio poblacional de Taiwán
title_fr_txt Association de la doxorubicine liposomale pégylée avec une amélioration de la survie globale par rapport à l'épirubicine dans le cancer du sein à un stade précoce : une étude basée sur la population de Taïwan
title_full Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan
title_fullStr Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan
title_full_unstemmed Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan
title_pt_txt Associação de doxorrubicina lipossomal peguilada com melhora na sobrevida global em comparação com epirrubicina no câncer de mama inicial: Um estudo populacional de Taiwan
title_short Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan
title_sort association of pegylated liposomal doxorubicin with improved overall survival compared with epirubicin in early-stage breast cancer: a population based study from taiwan
topic Oncology
General
Oncology
url https://www.dovepress.com/association-of-pegylated-liposomal-doxorubicin-with-improved-overall-s-peer-reviewed-fulltext-article-BCTT